Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG) von Anker, Christopher J., MD, Grossmann, Kenneth F., MD, PhD, Atkins, Michael B., MD, Suneja, Gita, MD, Tarhini, Ahmad A., MD, PhD, Kirkwood, John M., MD

Volltext

Surgical correction of aortic valve insufficiency after left ventricular assist device implantation von Atkins, B. Zane, MD, Hashmi, Zubair A., MD, Ganapathi, Asvin M., MD, Harrison, J. Kevin, MD, Hughes, G. Chad, MD, Rogers, Joseph G., MD, Milano, Carmelo A., MD

Volltext

Cancer Immunotherapy: Past Progress and Future Directions von Atkins, Michael B., MD, Sznol, Mario, MD

Volltext

A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia von Berry, Mark F., MD, Atkins, B. Zane, MD, Tong, Betty C., MD, Harpole, David H., MD, D'Amico, Thomas A., MD, Onaitis, Mark W., MD

Volltext

Pulmonary Segmentectomy by Thoracotomy or Thoracoscopy: Reduced Hospital Length of Stay With a Minimally-Invasive Approach von Atkins, B. Zane, MD, Harpole, David H., MD, Mangum, Jennifer H., BSN, Toloza, Eric M., MD, PhD, D’Amico, Thomas A., MD, Burfeind, William R., MD

Volltext

Impact of Oropharyngeal Dysphagia on Long-Term Outcomes of Lung Transplantation von Atkins, B. Zane, MD, Petersen, Rebecca P., MD, MS, Daneshmand, Mani A., MD, Turek, Joseph W., MD, PhD, Lin, Shu S., MD, PhD, Davis, R. Duane, MD

Volltext

Assessing Oropharyngeal Dysphagia After Lung Transplantation: Altered Swallowing Mechanisms and Increased Morbidity von Atkins, B. Zane, MD, Trachtenberg, Melissa S., MA, Prince-Petersen, Rebecca, MD, MSc, Vess, Gina, MA, Bush, Errol L., MD, Balsara, Keki R., MD, Lin, Shu S., MD, PhD, Davis, R. Duane, MD

Volltext

Short-term forecasts to inform the response to the Covid-19 epidemic in the UK von Funk, S, Abbott, S, Atkins, BD, Baguelin, M, Baillie, JK, Birrell, P, Blake, J, Bosse, NI, Burton, J, Carruthers, J, Davies, NG, De Angelis, D, Dyson, L, Edmunds, WJ, Eggo, RM, Ferguson, NM, Gaythorpe, K, Gorsich, E, Guyver-Fletcher, G, Hellewell, J, Hill, EM, Holmes, A, House, TA, Jewell, C, Jit, M, Jombart, T, Joshi, I, Keeling, MJ, Kendall, E, Knock, ES, Kucharski, AJ, Lythgoe, KA, Meakin, SR, Munday, JD, Openshaw, PJM, Overton, CE, Pagani, F, Pearson, J, Perez-Guzman, PN, Pellis, L, Scarabel, F, Semple, MG, Sherratt, K, Tang, M, Tildesley, MJ, Van Leeuwen, E, Whittles, LK

Volltext

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England von Davies, Nicholas G., Abbott, Sam, Barnard, Rosanna C., Jarvis, Christopher, Kucharski, Adam J., Munday, James D., Pearson, Carl A. B., Russell, Timothy W., Tully, Damien C., Washburne, Alex D., Wenseleers, Tom, Gimma, Amy, Waites, William, Wong, Kerry L. M., van Zandvoort, Kevin, Silverman, Justin D., Diaz-Ordaz, Karla, Keogh, Ruth, Eggo, Rosalind M., Funk, Sebastian, Jit, Mark, Atkins, Katherine E., Edmunds, W. John

Volltext

Microwave Structure Construction Capability Year 1 Accomplishments von Effinger, M. R., Albritton, L. M., Atkins, B. D., Bahr, C. W., Barmatz, M. B., Boothe, R.E., Bruce, R. W., Burt, A. O., Charnock, S. E., Dalton, J., Ethridge, E., Hanson, I. M., Hoppe, D. J., Huleis, J. N., Hutcheon, R., Gerling, J. F., Kaukler, W., Kimrey, H., King, A. J., Roy, S. Le, Mauro, S. L., Morgan, J. E., Meek, T., Otte, Q. H., Popok, D. P., Rickman, D. L., Roberts, Z. S., Sanchez, J., Shulman, H. S., Stride, S. L., Spence, T. J., Voecks, G. E., Wilkerson, Ryan P, F.Zhong, F.Zhong

Volltext bestellen

Microwave Structure Construction Capability Year One Accomplishments von Effinger, M R, Albritton, L M, Atkins, B D, Bahr, C W, Barmatz, M B, Boothe, R E, Bruce, R W, Burt, A O, Dalton, J, Ethridge, E, Hanson, I M, Hoppe, D J, Huleis, J N, Hutcheon, R, Gerling, J F, Kaukler, W F, Kimrey, H, King, A. J., Mauro, S L, Morgan, J E, Meek, T, Otte, Q H, Rickman, D L, Roberts, Z S, Sanchez, J, Shulman, H S, Stride, S L, Spence, T. J., Voecks, G E, Wilkerson, R P, Zhong, F

Volltext bestellen

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma von Weber, Jeffrey, Mandala, Mario, Del Vecchio, Michele, Gogas, Helen J, Arance, Ana M, Cowey, C. Lance, Dalle, Stéphane, Schenker, Michael, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Grob, Jean-Jacques, Butler, Marcus O, Middleton, Mark R, Maio, Michele, Atkinson, Victoria, Queirolo, Paola, Gonzalez, Rene, Kudchadkar, Ragini R, Smylie, Michael, Meyer, Nicolas, Mortier, Laurent, Atkins, Michael B, Long, Georgina V, Bhatia, Shailender, Lebbé, Celeste, Rutkowski, Piotr, Yokota, Kenji, Yamazaki, Naoya, Kim, Tae M, de Pril, Veerle, Sabater, Javier, Qureshi, Anila, Larkin, James, Ascierto, Paolo A

Volltext

Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions von Atkins, M.B., Clark, J.I., Quinn, D.I.

Volltext

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial von Haas, Naomi B, Dr, Manola, Judith, MS, Uzzo, Robert G, Prof, Flaherty, Keith T, MD, Wood, Christopher G, Prof, Kane, Christopher, Prof, Jewett, Michael, Prof, Dutcher, Janice P, Prof, Atkins, Michael B, Prof, Pins, Michael, Prof, Wilding, George, Prof, Cella, David, Prof, Wagner, Lynne, Prof, Matin, Surena, Prof, Kuzel, Timothy M, Prof, Sexton, Wade J, Prof, Wong, Yu-Ning, MD, Choueiri, Toni K, MD, Pili, Roberto, Prof, Puzanov, Igor, MD, Kohli, Manish, MD, Stadler, Walter, Prof, Carducci, Michael, Prof, Coomes, Robert, DiPaola, Robert S, Prof

Volltext

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice von Chow, F.Y., Nikolic-Paterson, D.J., Ozols, E., Atkins, R.C., Rollin, B.J., Tesch, G.H.

Volltext

Acute peri-operative neurocognitive disorders: a narrative review von Evered, L, Atkins, K, Silbert, B, Scott, D A

Volltext

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain von Tawbi, Hussein A, Forsyth, Peter A, Algazi, Alain, Hamid, Omid, Hodi, F. Stephen, Moschos, Stergios J, Khushalani, Nikhil I, Lewis, Karl, Lao, Christopher D, Postow, Michael A, Atkins, Michael B, Ernstoff, Marc S, Reardon, David A, Puzanov, Igor, Kudchadkar, Ragini R, Thomas, Reena P, Tarhini, Ahmad, Pavlick, Anna C, Jiang, Joel, Avila, Alexandre, Demelo, Sheena, Margolin, Kim

Volltext

Which drug, and when, for patients with BRAF-mutant melanoma? von Jang, Sekwon, MD, Atkins, Michael B, Prof

Volltext

PD-L1 expression in nonclear-cell renal cell carcinoma von Choueiri, T.K., Fay, A.P., Gray, K.P., Callea, M., Ho, T.H., Albiges, L., Bellmunt, J., Song, J., Carvo, I., Lampron, M., Stanton, M.L., Hodi, F.S., McDermott, D.F., Atkins, M.B., Freeman, G.J., Hirsch, M.S., Signoretti, S.

Volltext

The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma von Shoushtari, Alexander N., Munhoz, Rodrigo R., Kuk, Deborah, Ott, Patrick A., Johnson, Douglas B., Tsai, Katy K., Rapisuwon, Suthee, Eroglu, Zeynep, Sullivan, Ryan J., Luke, Jason J., Gangadhar, Tara C., Salama, April K. S., Clark, Varina, Burias, Clare, Puzanov, Igor, Atkins, Michael B., Algazi, Alain P., Ribas, Antoni, Wolchok, Jedd D., Postow, Michael A.

Volltext